KL Acquisition Corp
KLAQW
NASDAQ Capital Market0.00
USD
+0.00
- -
CIK
0001823323
ISIN
CA48345H1055
CUSIP
48345H105
Return %
Stock
S&P500
1Y
-99.22
18.46
3Y
-99.73
64.72
5Y
-99.73
72.79
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Richard Gumer
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 111 West 33rd Street New York City NY United States of America
- IPO Date
- Mar 1, 2021
- CIK
- 0001823323
- Similar Companies
- Business
- KL Acquisition Corp is a blank check company incorporated in Delaware with a primary business objective to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses or entities, primarily targeting the healthcare and healthcare-related sectors. The company does not manufacture or sell products but operates as a special purpose acquisition company (SPAC) that raises capital to acquire or merge with an operating business. KL Acquisition Corp's corporate actions include issuing units consisting of Class A common stock, redeemable warrants, and rights for public investment. The company is headquartered in New York, USA. In terms of recent major developments, KL Acquisition Corp amended its certificate of incorporation in late 2022 to allow for a financial unwinding process, whereby it redeemed outstanding public shares prior to year-end 2022, resulting in the company ultimately undergoing dissolution, liquidation, and winding up as directed by its Board of Directors. This strategic move marked a significant operational change to exit the public market. There have been no reported acquisitions, new product launches, or strategic partnerships since that unwinding decision. Prior to these events, the company had focused on seeking an acquisition target in the healthcare sector but had not completed a business combination as of 2025. The company remains primarily a shell entity for potential future business transactions should conditions change. Thus, KL Acquisition Corp mainly offers investors access to capital intended for business combinations in healthcare but most recently has been engaged in the process of unwinding its operations and redeeming shares ahead of dissolution.